The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …

This review examines the intersection of the HIV and SARS-CoV-2 pandemics. People with
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …

Background We analyzed humoral and cellular immune responses induced by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines in …

Abstract Purpose of Review HIV/AIDS and COVID-19 have been the major pandemics
overwhelming our times. Given the enduring immune disfunction featuring people living with …

This study aimed to investigate the immunogenicity to SARS‐CoV‐2 and evasive
subvariants BA. 4/5 in people living with HIV (PLWH) following a third booster shot of …

Objective: To evaluate the potential factors for predicting seroconversion due to the
coronavirus disease 2019 (COVID-19) vaccine in people living with HIV (PLWH). Method …

Background: Our aim was to estimate the rates of not achieving a robust/above-average
humoral response to the COVID-19 mRNA vaccine in people living with HIV (PLWH) who …

Background The COVIH study is a prospective coronavirus disease 2019 (COVID-19)
vaccination study in 1154 people with HIV (PWH), of whom 14% showed reduced antibody …

Background Data on SARS-CoV-2 mRNA vaccine immunogenicity in people living with
human immunodeficiency virus (PLWH) and discordant immune response (DIR) are …

To quantify the pooled rate and risk ratio of seroconversion following the uncomplete,
complete, or booster dose of COVID-19 vaccines in patients living with HIV. PubMed …